UTAH VALLEY REGIONAL MED. CTR.
- Type
- Teaching hospital
- Where
- PROVO, UT
- Medicare CCN
- 460001
- Received
- $826,585 in 133 records, 2019 ($150,877 general, $675,707 research)
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2019 | General payment | 55 | $150,877 |
| 2019 | Research payment | 78 | $675,707 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $216,994 | 2019 |
| Siemens Medical Solutions USA, Inc. | 3 | $123,842 | 2019 |
| ONY Biotech Inc. | 1 | $96,000 | 2019 |
| Abbott Laboratories | 38 | $85,465 | 2019 |
| Novo Nordisk AS | 10 | $76,093 | 2019 |
| Edwards Lifesciences Corporation | 16 | $61,181 | 2019 |
| Braincoolinc | 1 | $50,000 | 2019 |
| Sterilmed, Inc. | 11 | $25,915 | 2019 |
| Boston Scientific Corporation | 1 | $15,000 | 2019 |
| ACELL, INC. | 8 | $14,977 | 2019 |
| GE HEALTHCARE | 9 | $14,788 | 2019 |
| AstraZeneca UK Limited | 2 | $11,062 | 2019 |
| Medical Device Business Services, Inc. | 3 | $7,250 | 2019 |
| BioFire Diagnostics, LLC | 1 | $5,850 | 2019 |
| Cook Research Incorporated | 7 | $4,467 | 2019 |
| Masimo Corporation | 5 | $3,153 | 2019 |
| Stryker Corporation | 2 | $2,966 | 2019 |
| CSL Behring | 2 | $2,528 | 2019 |
| Mallinckrodt Enterprises LLC | 1 | $2,000 | 2019 |
| Janssen Biotech, Inc. | 1 | $2,000 | 2019 |
| ABBVIE INC. | 1 | $2,000 | 2019 |
| KLS-Martin L.P. | 1 | $1,500 | 2019 |
| Eisai Inc. | 1 | $1,000 | 2019 |
| OraSure Technologies Inc. | 2 | $305 | 2019 |
| 3M Company | 1 | $150 | 2019 |
| Linvatec Corporation | 1 | $91 | 2019 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Research payment | 78 | $675,707 |
| Charitable Contribution | 2 | $50,047 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 16 | $36,554 |
| Education | 18 | $22,223 |
| Grant | 7 | $21,779 |
| Space rental or facility fees (teaching hospital only) | 6 | $11,000 |
| Gift | 6 | $9,271 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2019-12-31 | Siemens Medical Solutions USA, Inc. | $119,811 | Research payment | Cash or cash equivalent | Enterprise reading and reporting investigation | 2019 | |
| 2019-12-31 | Siemens Medical Solutions USA, Inc. | $3,984 | Research payment | Cash or cash equivalent | S3000 HELX Device, US - Ultrasound Systems | Ultrasound ARFI Cervical Assessment of Preterm Delivery | 2019 |
| 2019-12-31 | Stryker Corporation | $2,848 | Gift | In-kind items and services | SYMMETRY PLUS TREATMENT RECLINER Device, FURNITURE | 2019 | |
| 2019-12-31 | Masimo Corporation | $1,867 | Education | In-kind items and services | EMMA and ISA Device, Devices | 2019 | |
| 2019-12-31 | AstraZeneca Pharmaceuticals LP | $1,566 | Research payment | In-kind items and services | This is a randomized open label multi center global Phase III study to assess the efficacy and safety of durvalumab plus | 2019 | |
| 2019-12-31 | Masimo Corporation | $969 | Education | In-kind items and services | rainbow Acoustic Monitoring Device, Devices | 2019 | |
| 2019-12-31 | AstraZeneca UK Limited | $812 | Research payment | In-kind items and services | IMFINZI Drug, Oncology | This is a randomized open label multi center global Phase III study to determine the efficacy and safety of MEDI4736 as | 2019 |
| 2019-12-31 | Masimo Corporation | $221 | Education | In-kind items and services | SET and rainbow SET Device, Devices | 2019 | |
| 2019-12-31 | Abbott Laboratories | $150 | Research payment | In-kind items and services | TriClip Tricuspid Repair Device Device, Cardiac Arrhythmias and Heart Failure | TRILUMINATE Pivotal Trial | 2019 |
| 2019-12-31 | Stryker Corporation | $118 | Gift | In-kind items and services | CUB Device, BEDS | 2019 | |
| 2019-12-31 | Linvatec Corporation | $91 | Grant | In-kind items and services | HALL POWER Device, ORTHOPEDIC SURGERY | 2019 | |
| 2019-12-31 | Siemens Medical Solutions USA, Inc. | $47 | Charitable Contribution | In-kind items and services | 2019 | ||
| 2019-12-31 | Abbott Laboratories | $45 | Research payment | In-kind items and services | TriClip Tricuspid Repair Device Device, Cardiac Arrhythmias and Heart Failure | TRILUMINATE Pivotal Trial | 2019 |
| 2019-12-19 | Abbott Laboratories | $10,000 | Research payment | Cash or cash equivalent | Mitra Clip system Device, Cardiac Arrhythmias and Heart Failure | Clinical TRIal to EvaLUate Cardiovascular OutcoMes IN PAtients Treated with the Tricuspid ValvE Repair System Pivotal | 2019 |
| 2019-12-19 | Sterilmed, Inc. | $2,630 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-12-12 | Abbott Laboratories | $2,750 | Research payment | Cash or cash equivalent | Optical Coherence Tomography (OCT) Device, Cardiac Arrhythmias and Heart Failure | Optical Coherence Tomography (OCT) Guided Coronary Stent Implantation Compared to Angiography: a Multicenter Randomized | 2019 |
| 2019-12-12 | Abbott Laboratories | $250 | Research payment | Cash or cash equivalent | MultiPoint Pacing Device, Cardiac Arrhythmias and Heart Failure | MultiPoint Pacing Post Market Study | 2019 |
| 2019-11-14 | Sterilmed, Inc. | $1,310 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-11-13 | Edwards Lifesciences Corporation | $1,000 | Research payment | Cash or cash equivalent | Edwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart Valves | Partner II S3iCAP 2010-2012 | 2019 |
| 2019-11-07 | GE HEALTHCARE | $3,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Device, MAGNETIC RESONANCE | 2019 | |
| 2019-11-07 | Abbott Laboratories | $608 | Research payment | Cash or cash equivalent | Mitra Clip system Device, Cardiac Arrhythmias and Heart Failure | A Contemporary, Prospective Study Evaluating Real-world Experience of Performance and Safety for the Next Generation of | 2019 |
| 2019-10-31 | GE HEALTHCARE | $3,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Device, MAGNETIC RESONANCE | 2019 | |
| 2019-10-31 | GE HEALTHCARE | $1,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Device, MAGNETIC RESONANCE | 2019 | |
| 2019-10-30 | Abbott Laboratories | $1,467 | Research payment | Cash or cash equivalent | Nanostim Leadless Pacemaker Device, Cardiac Arrhythmias and Heart Failure | A safety and effectiveness trial for a leadless pacemaker system | 2019 |
| 2019-10-25 | AstraZeneca Pharmaceuticals LP | $5,372 | Research payment | Cash or cash equivalent | Actual Practice Evaluation of Predictors for Major Adverse Cardiovascular Events and Bleeding Outcomes following Percuta | 2019 | |
| 2019-10-18 | Cook Research Incorporated | $2,300 | Research payment | Cash or cash equivalent | Cook Medical Self-Expanding Stent Device, Peripheral Intervention | Evaluation of the Zilver Vena Venous Stent in the Treatment of Symptomatic | 2019 |
| 2019-10-18 | Cook Research Incorporated | $313 | Research payment | Cash or cash equivalent | Cook Medical Self-Expanding Stent Device, Peripheral Intervention | Evaluation of the Zilver Vena Venous Stent in the Treatment of Symptomatic | 2019 |
| 2019-10-14 | OraSure Technologies Inc. | $275 | Gift | In-kind items and services | Device, HIV | 2019 | |
| 2019-10-14 | OraSure Technologies Inc. | $30 | Gift | In-kind items and services | Device, HIV | 2019 | |
| 2019-10-10 | Abbott Laboratories | $750 | Research payment | Cash or cash equivalent | Mitra Clip system Device, Cardiac Arrhythmias and Heart Failure | A Contemporary, Prospective Study Evaluating Real-world Experience of Performance and Safety for the Next Generation of | 2019 |
| 2019-10-08 | ACELL, INC. | $1,397 | Education | Cash or cash equivalent | 2019 | ||
| 2019-10-03 | Abbott Laboratories | $5,250 | Research payment | Cash or cash equivalent | Mitra Clip system Device, Vascular | Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitr | 2019 |
| 2019-09-26 | Novo Nordisk AS | $8,545 | Research payment | Cash or cash equivalent | HAEM-4436 | 2019 | |
| 2019-09-18 | Edwards Lifesciences Corporation | $27,375 | Research payment | Cash or cash equivalent | Edwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart Valves | PARTNER II 2010-12 | 2019 |
| 2019-09-10 | Novo Nordisk AS | $500 | Research payment | Cash or cash equivalent | HAEM-4436 | 2019 | |
| 2019-09-05 | ACELL, INC. | $2,557 | Education | Cash or cash equivalent | 2019 | ||
| 2019-09-04 | Sterilmed, Inc. | $3,232 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-09-04 | Sterilmed, Inc. | $1,490 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-09-03 | GE HEALTHCARE | $2,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Device, ULTRASOUND | 2019 | |
| 2019-08-30 | Novo Nordisk AS | $1,201 | Research payment | Cash or cash equivalent | HAEM-4436 | 2019 | |
| 2019-08-29 | Abbott Laboratories | $750 | Research payment | Cash or cash equivalent | Mitra Clip system Device, Vascular | ardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitra | 2019 |
| 2019-08-28 | Edwards Lifesciences Corporation | $750 | Research payment | Cash or cash equivalent | Early Feasibility Study of the CardiAQ Transcatheter Mitral Valve Implantation TMVI System 2013-05C | 2019 | |
| 2019-08-28 | Edwards Lifesciences Corporation | $750 | Research payment | Cash or cash equivalent | Edwards Cardioband System ACTIVE Pivotal Clinical Trial 2017-05 | 2019 | |
| 2019-08-27 | CSL Behring | $28 | Education | In-kind items and services | Kcentra Biological, Trauma (Emergency, Injury, Surgery) | 2019 | |
| 2019-08-23 | GE HEALTHCARE | $1,013 | Grant | Cash or cash equivalent | Device, ULTRASOUND | 2019 | |
| 2019-08-23 | GE HEALTHCARE | $250 | Grant | Cash or cash equivalent | Device, ULTRASOUND | 2019 | |
| 2019-08-20 | Braincoolinc | $50,000 | Charitable Contribution (2 payments) | In-kind items and services | IQool System Device, Nuerology | 2019 | |
| 2019-08-14 | Abbott Laboratories | $702 | Research payment | Cash or cash equivalent | MultiPoint Pacing Device, Cardiac Arrhythmias and Heart Failure | MultiPoint Pacing Post Market Study | 2019 |
| 2019-08-07 | Edwards Lifesciences Corporation | $13,650 | Research payment | Cash or cash equivalent | Edwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart Valves | PARTNER II 2010-12 | 2019 |
| 2019-08-06 | Abbott Laboratories | $350 | Research payment | Cash or cash equivalent | Mitra Clip system Device, Vascular | Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitr | 2019 |
| 2019-08-01 | Sterilmed, Inc. | $3,033 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-07-31 | Abbott Laboratories | $6,281 | Research payment | Cash or cash equivalent | Nanostim Leadless Pacemaker Device, Cardiac Arrhythmias and Heart Failure | A safety and effectiveness trial for a leadless pacemaker system | 2019 |
| 2019-07-31 | Abbott Laboratories | $5,093 | Research payment | Cash or cash equivalent | Trifecta Valve Device, Cardiac Arrhythmias and Heart Failure | Long Term Follow Up of the St. Jude Medical Trifecta Valve | 2019 |
| 2019-07-31 | CSL Behring | $2,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2019 | ||
| 2019-07-31 | Abbott Laboratories | $1,465 | Research payment | Cash or cash equivalent | Mitra Clip system Device, Cardiac Arrhythmias and Heart Failure | A Contemporary, Prospective Study Evaluating Real-world Experience of Performance and Safety for the Next Generation of | 2019 |
| 2019-07-30 | Novo Nordisk AS | $9,301 | Research payment | Cash or cash equivalent | HAEM-4436 | 2019 | |
| 2019-07-25 | Abbott Laboratories | $750 | Research payment | Cash or cash equivalent | Nanostim Leadless Pacemaker Device, Cardiac Arrhythmias and Heart Failure | A safety and effectiveness trial for a leadless pacemaker system | 2019 |
| 2019-07-16 | Abbott Laboratories | $169 | Education | In-kind items and services | Reagent Device, Diagnostics | 2019 | |
| 2019-07-16 | Abbott Laboratories | $92 | Education | In-kind items and services | Reagent Device, Diagnostics | 2019 | |
| 2019-07-16 | Abbott Laboratories | $92 | Education | In-kind items and services | Reagent Device, Diagnostics | 2019 | |
| 2019-07-15 | Abbott Laboratories | $3,708 | Education | In-kind items and services | Reagent Device, Diagnostics | 2019 | |
| 2019-07-15 | GE HEALTHCARE | $600 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-07-15 | Cook Research Incorporated | $100 | Research payment | Cash or cash equivalent | Cook Medical Self-Expanding Stent Device, Peripheral Intervention | Evaluation of the Zilver Vena Venous Stent in the Treatment of Symptomatic | 2019 |
| 2019-07-12 | ACELL, INC. | $2,557 | Education | Cash or cash equivalent | 2019 | ||
| 2019-07-12 | ACELL, INC. | $1,100 | Education | Cash or cash equivalent | 2019 | ||
| 2019-07-09 | Masimo Corporation | $44 | Education | In-kind items and services | rainbow Acoustic Monitoring Device, Devices | 2019 | |
| 2019-06-26 | Sterilmed, Inc. | $3,691 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-06-25 | Novo Nordisk AS | $25,190 | Research payment | Cash or cash equivalent | HAEM-4436 | 2019 | |
| 2019-06-24 | ACELL, INC. | $1,933 | Education | Cash or cash equivalent | 2019 | ||
| 2019-06-19 | KLS-Martin L.P. | $1,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2019 | ||
| 2019-06-14 | ACELL, INC. | $2,557 | Education | Cash or cash equivalent | 2019 | ||
| 2019-06-11 | Abbott Laboratories | $2,539 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-06-05 | Edwards Lifesciences Corporation | $750 | Research payment | Cash or cash equivalent | Edwards Cardioband System ACTIVE Pivotal Clinical Trial 2017-05 | 2019 | |
| 2019-06-01 | 3M Company | $150 | Gift | In-kind items and services | 2019 | ||
| 2019-05-29 | Sterilmed, Inc. | $2,377 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-05-28 | Novo Nordisk AS | $8,100 | Research payment | Cash or cash equivalent | HAEM-4436 | 2019 | |
| 2019-05-22 | BioFire Diagnostics, LLC | $5,850 | Gift | In-kind items and services | BioFire FilmArray Pneumonia 30 Pouch Kit (RFIT-ASY-0144) Device, Clinical Diagnostics | 2019 | |
| 2019-05-15 | Edwards Lifesciences Corporation | $4,200 | Research payment | Cash or cash equivalent | Edwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart Valves | PARTNER II 2010-12 | 2019 |
| 2019-05-15 | Medical Device Business Services, Inc. | $1,500 | Research payment | Cash or cash equivalent | WAveCrest Vs. Watchman TranssEptal LAA Closure to Reduce AF-Mediated STroke 2 | 2019 | |
| 2019-05-15 | Medical Device Business Services, Inc. | $750 | Research payment | Cash or cash equivalent | WAveCrest Vs. Watchman TranssEptal LAA Closure to Reduce AF-Mediated STroke 2 | 2019 | |
| 2019-05-15 | Abbott Laboratories | $337 | Research payment | Cash or cash equivalent | MultiPoint Pacing Device, Cardiac Arrhythmias and Heart Failure | MultiPoint Pacing Post Market Study | 2019 |
| 2019-05-10 | Medical Device Business Services, Inc. | $5,000 | Research payment | Cash or cash equivalent | WAveCrest Vs. Watchman TranssEptal LAA Closure to Reduce AF-Mediated STroke 2 | 2019 | |
| 2019-05-08 | Abbott Laboratories | $5,455 | Research payment | Cash or cash equivalent | Mitra Clip system Device, Cardiac Arrhythmias and Heart Failure | A Contemporary, Prospective Study Evaluating Real-world Experience of Performance and Safety for the Next Generation of | 2019 |
| 2019-05-03 | Abbott Laboratories | $2,520 | Research payment | Cash or cash equivalent | Mitra Clip system Device, Vascular | Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitr | 2019 |
| 2019-05-03 | Abbott Laboratories | $750 | Research payment | Cash or cash equivalent | Mitra Clip system Device, Vascular | Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitr | 2019 |
| 2019-04-26 | ACELL, INC. | $2,557 | Education | Cash or cash equivalent | 2019 | ||
| 2019-04-25 | Novo Nordisk AS | $16,200 | Research payment | Cash or cash equivalent | HAEM-4436 | 2019 | |
| 2019-04-25 | Sterilmed, Inc. | $1,639 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-04-25 | Eisai Inc. | $1,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Fycompa Drug, Neurology | 2019 | |
| 2019-04-24 | Abbott Laboratories | $6,581 | Research payment | Cash or cash equivalent | Nanostim Leadless Pacemaker Device, Cardiac Arrhythmias and Heart Failure | A safety and effectiveness trial for a leadless pacemaker system | 2019 |
| 2019-04-15 | Cook Research Incorporated | $300 | Research payment | Cash or cash equivalent | Evaluation of the Zilver Vena Venous Stent in the Treatment of Symptomatic | 2019 | |
| 2019-03-28 | Novo Nordisk AS | $4,050 | Research payment | Cash or cash equivalent | HAEM-4436 | 2019 | |
| 2019-03-28 | Abbott Laboratories | $2,500 | Research payment | Cash or cash equivalent | Mitra Clip system Device, Vascular | ardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitra | 2019 |
| 2019-03-28 | Abbott Laboratories | $2,500 | Research payment | Cash or cash equivalent | Mitra Clip system Device, Vascular | ardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitra | 2019 |
| 2019-03-28 | Abbott Laboratories | $650 | Research payment | Cash or cash equivalent | Mitra Clip system Device, Vascular | ardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitra | 2019 |
| 2019-03-26 | Sterilmed, Inc. | $2,121 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-03-15 | Edwards Lifesciences Corporation | $7,000 | Research payment | Cash or cash equivalent | Edwards SAPIEN XT Transcatheter Heart Valve Device, Transcatheter Heart Valves | PARTNER II 2010-12 | 2019 |
| 2019-03-15 | Sterilmed, Inc. | $2,797 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-03-14 | Abbott Laboratories | $750 | Research payment | Cash or cash equivalent | Mitra Clip system Device, Vascular | ardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitra | 2019 |
| 2019-03-07 | Abbott Laboratories | $805 | Research payment | Cash or cash equivalent | Absorb Device, Vascular | A Clinical Evaluation of Absorb BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects | 2019 |
| 2019-03-06 | Edwards Lifesciences Corporation | $1,500 | Research payment | Cash or cash equivalent | Early Feasibility Study of the CardiAQ Transcatheter Mitral Valve Implantation TMVI System 2013-05C | 2019 | |
| 2019-03-06 | Edwards Lifesciences Corporation | $500 | Research payment | Cash or cash equivalent | Early Feasibility Study of the CardiAQ Transcatheter Mitral Valve Implantation TMVI System 2013-05C | 2019 | |
| 2019-03-06 | Edwards Lifesciences Corporation | $250 | Research payment | Cash or cash equivalent | Early Feasibility Study of the CardiAQ Transcatheter Mitral Valve Implantation TMVI System 2013-05C | 2019 | |
| 2019-03-01 | Edwards Lifesciences Corporation | $66 | Research payment | Cash or cash equivalent | Edwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart Valves | PARTNERII 2010-12 | 2019 |
| 2019-02-26 | Novo Nordisk AS | $3,000 | Research payment | Cash or cash equivalent | HAEM-4436 | 2019 | |
| 2019-02-26 | Novo Nordisk AS | $5 | Research payment | In-kind items and services | HAEM-4436 | 2019 | |
| 2019-02-21 | ABBVIE INC. | $2,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Lupron Depot Drug, Endocrinology | 2019 | |
| 2019-02-20 | Edwards Lifesciences Corporation | $975 | Research payment | Cash or cash equivalent | Edwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart Valves | Early-TAVR Trial 2016-07 | 2019 |
| 2019-02-19 | AstraZeneca UK Limited | $10,250 | Research payment | Cash or cash equivalent | IMFINZI Drug, Oncology | This is a randomized open label multi center global Phase III study to determine the efficacy and safety of MEDI4736 as | 2019 |
| 2019-02-14 | ONY Biotech Inc. | $96,000 | Research payment | Cash or cash equivalent | Infasurf Drug, Product | AERO-02 | 2019 |
| 2019-02-06 | Boston Scientific Corporation | $15,000 | Grant | Cash or cash equivalent | GENERAL - ERECTILE DYSFUNCTION Device, ERECTILE DYSFUNCTION | 2019 | |
| 2019-02-06 | Abbott Laboratories | $6,690 | Research payment | Cash or cash equivalent | Mitra Clip system Device, Cardiac Arrhythmias and Heart Failure | A Contemporary, Prospective Study Evaluating Real-world Experience of Performance and Safety for the Next Generation of | 2019 |
| 2019-02-06 | Abbott Laboratories | $5,093 | Research payment | Cash or cash equivalent | Trifecta Valve Device, Cardiac Arrhythmias and Heart Failure | Long Term Follow Up of the St. Jude Medical Trifecta Valve | 2019 |
| 2019-02-06 | Edwards Lifesciences Corporation | $500 | Research payment | Cash or cash equivalent | Edwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart Valves | PARTNER II 2010-12 | 2019 |
| 2019-02-06 | Abbott Laboratories | $337 | Research payment | Cash or cash equivalent | MultiPoint Pacing Device, Cardiac Arrhythmias and Heart Failure | MultiPoint Pacing Post Market Study | 2019 |
| 2019-02-06 | Edwards Lifesciences Corporation | $250 | Research payment | Cash or cash equivalent | Early Feasibility Study of the CardiAQ Transcatheter Mitral Valve Implantation TMVI System 2013-05C | 2019 | |
| 2019-02-05 | Mallinckrodt Enterprises LLC | $2,000 | Grant | Cash or cash equivalent | 2019 | ||
| 2019-02-05 | ACELL, INC. | $317 | Education | Cash or cash equivalent | 2019 | ||
| 2019-01-31 | AstraZeneca Pharmaceuticals LP | $66,871 | Research payment | Cash or cash equivalent | This is a randomized open label multi center global Phase III study to assess the efficacy and safety of durvalumab plus | 2019 | |
| 2019-01-30 | Abbott Laboratories | $5,883 | Research payment | Cash or cash equivalent | Nanostim Leadless Pacemaker Device, Cardiac Arrhythmias and Heart Failure | A safety and effectiveness trial for a leadless pacemaker system | 2019 |
| 2019-01-29 | Masimo Corporation | $51 | Education | In-kind items and services | EMMA and ISA Device, Devices | 2019 | |
| 2019-01-24 | Sterilmed, Inc. | $1,589 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-01-24 | Abbott Laboratories | $250 | Research payment | Cash or cash equivalent | Trifecta Valve Device, Cardiac Arrhythmias and Heart Failure | Long Term Follow Up of the St. Jude Medical Trifecta Valve | 2019 |
| 2019-01-23 | Janssen Biotech, Inc. | $2,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Erleada Drug, Oncology | 2019 | |
| 2019-01-18 | Edwards Lifesciences Corporation | $1,665 | Research payment | Cash or cash equivalent | Edwards Cardioband System ACTIVE Pivotal Clinical Trial 2017-05 | 2019 | |
| 2019-01-17 | Abbott Laboratories | $350 | Research payment | Cash or cash equivalent | Mitra Clip system Device, Vascular | Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitr | 2019 |
| 2019-01-16 | Cook Research Incorporated | $750 | Research payment | Cash or cash equivalent | Evaluation of the Zilver Vena Venous Stent in the Treatment of Symptomatic | 2019 | |
| 2019-01-16 | Cook Research Incorporated | $600 | Research payment | Cash or cash equivalent | Evaluation of the Zilver Vena Venous Stent in the Treatment of Symptomatic | 2019 | |
| 2019-01-16 | Cook Research Incorporated | $104 | Research payment | Cash or cash equivalent | Evaluation of the Zilver Vena Venous Stent in the Treatment of Symptomatic | 2019 | |
| 2019-01-09 | GE HEALTHCARE | $3,000 | Grant | Cash or cash equivalent | Device, ULTRASOUND | 2019 | |
| 2019-01-09 | GE HEALTHCARE | $425 | Grant | Cash or cash equivalent | Device, ULTRASOUND | 2019 | |
| 2019-01-07 | AstraZeneca Pharmaceuticals LP | $143,183 | Research payment | Cash or cash equivalent | COPD Readmissions in Patients with Peripheral Eosinophilla | 2019 | |
| 2019-01-03 | Abbott Laboratories | $750 | Research payment | Cash or cash equivalent | Absorb Device, Vascular | A Clinical Evaluation of Absorb BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects | 2019 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Provo, UT, county Utah County, UT, state Utah; placed by its city name.
| Measure | Place (city or town) Provo, UT | County Utah County, UT | State Utah |
|---|---|---|---|
| Population B01003 | 114,766 | 705,400 | 3,392,331 |
| Population, 2020 census P1 | 115,162 | 659,399 | 3,271,616 |
| Median age B01002 | 23.6 | 25.8 | 32.0 |
| Under 18 B01001 | 18.7% | 31.6% | 27.8% |
| 65 and over B01001 | 6.7% | 7.9% | 11.9% |
| Households B11001 | 34,022 | 203,018 | 1,124,822 |
| Foreign born B05002 | 12.5% | 8.2% | 8.9% |
| Median household income B19013 | $64,171 | $100,671 | $95,166 |
| Median family income B19113 | $73,450 | $110,986 | $109,675 |
| Per capita income B19301 | $27,822 | $37,082 | $40,873 |
| Poverty rate B17001 | 23.0% | 8.7% | 8.5% |
| Unemployment rate B23025 | 5.1% | 3.8% | 3.6% |
| Civilian labor force B23025 | 69,670 | 363,771 | 1,778,106 |
| Mean commute (minutes) B08013 | 18.4 | 22.6 | 22.1 |
| Bachelor's degree or higher B15003 | 45.2% | 44.4% | 37.7% |
| Housing units B25001 | 35,944 | 211,066 | 1,223,468 |
| Owner-occupied B25003 | 39.4% | 68.3% | 70.2% |
| Renters B25003 | 60.6% | 31.7% | 29.8% |
| Median home value B25077 | $467,200 | $538,700 | $489,400 |
| Median gross rent B25064 | $1,193 | $1,541 | $1,496 |
| White, not Hispanic B03002 | 70.8% | 77.6% | 74.7% |
| Black B03002 | 1.1% | 0.7% | 1.1% |
| Hispanic or Latino B03002 | 19.2% | 14.5% | 15.9% |
| Asian B03002 | 2.2% | 1.5% | 2.4% |
| American Indian and Alaska Native B03002 | 0.2% | 0.2% | 0.6% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Provo, UT.
Comments